Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 625 to 630 of 630 entries
Sorted by: Best Match Show Resources per page
Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma.

Blood advances

Dave H, Terpilowski M, Mai M, Toner K, Grant M, Stanojevic M, Lazarski CA, Shibli A, Bien SA, Maglo P, Hoq F, Schore R, Glenn MJ, Hu B, Hanley PJ, Ambinder RF, Bollard CM.
PMID: 34495306
Blood Adv. 2021 Sep 08; doi: 10.1182/bloodadvances.2021005343. Epub 2021 Sep 08.

Hodgkin Lymphoma (HL) Reed Sternberg cells express tumor associated antigens (TAA) that are potential targets for cellular therapies. We recently demonstrated that TAA specific T cells (TAA-T) targeting WT1, PRAME and Survivin were safe and associated with prolonged time...

Cite
Dave H, Terpilowski M, Mai M, et al. Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma. Blood Adv. 2021;doi: 10.1182/bloodadvances.2021005343.
Dave, H., Terpilowski, M., Mai, M., Toner, K., Grant, M., Stanojevic, M., Lazarski, C. A., Shibli, A., Bien, S. A., Maglo, P., Hoq, F., Schore, R., Glenn, M. J., Hu, B., Hanley, P. J., Ambinder, R. F., & Bollard, C. M. (2021). Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma. Blood advances, . https://doi.org/10.1182/bloodadvances.2021005343
Dave, Hema, et al. "Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma." Blood advances vol. (2021). doi: https://doi.org/10.1182/bloodadvances.2021005343
Dave H, Terpilowski M, Mai M, Toner K, Grant M, Stanojevic M, Lazarski CA, Shibli A, Bien SA, Maglo P, Hoq F, Schore R, Glenn MJ, Hu B, Hanley PJ, Ambinder RF, Bollard CM. Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma. Blood Adv. 2021 Sep 08; doi: 10.1182/bloodadvances.2021005343. Epub 2021 Sep 08. PMID: 34495306.
Copy Download .nbib Format: NLM
A critical analysis of te Tiriti o Waitangi application in primary health organisations in Aotearoa New Zealand: Findings from a nationwide survey.

Health & social care in the community

Kidd J, Came H, Doole C, Rae N.
PMID: 33970523
Health Soc Care Community. 2022 Jan;30(1):e105-e112. doi: 10.1111/hsc.13417. Epub 2021 May 10.

Primary health is at the forefront of efforts to address health inequities. Effective primary health care keeps people well and improves longevity and quality of life. The persistence of health inequities, particularly between Indigenous peoples and non-Indigenous peoples globally,...

Cite
Kidd J, Came H, Doole C, et al. A critical analysis of te Tiriti o Waitangi application in primary health organisations in Aotearoa New Zealand: Findings from a nationwide survey. Health Soc Care Community. 2021;30(1):e105-e112doi: 10.1111/hsc.13417.
Kidd, J., Came, H., Doole, C., & Rae, N. (2022). A critical analysis of te Tiriti o Waitangi application in primary health organisations in Aotearoa New Zealand: Findings from a nationwide survey. Health & social care in the community, 30(1), e105-e112. https://doi.org/10.1111/hsc.13417
Kidd, Jacquie, et al. "A critical analysis of te Tiriti o Waitangi application in primary health organisations in Aotearoa New Zealand: Findings from a nationwide survey." Health & social care in the community vol. 30,1 (2022): e105-e112. doi: https://doi.org/10.1111/hsc.13417
Kidd J, Came H, Doole C, Rae N. A critical analysis of te Tiriti o Waitangi application in primary health organisations in Aotearoa New Zealand: Findings from a nationwide survey. Health Soc Care Community. 2022 Jan;30(1):e105-e112. doi: 10.1111/hsc.13417. Epub 2021 May 10. PMID: 33970523.
Copy Download .nbib Format: NLM
Mosquito-Borne Viral Pathogens Detected in Zambia: A Systematic Review.

Pathogens (Basel, Switzerland)

Velu RM, Kwenda G, Libonda L, Chisenga CC, Flavien BN, Chilyabanyama ON, Simunyandi M, Bosomprah S, Sande NC, Changula K, Muleya W, Mburu MM, Mubemba B, Chitanga S, Tembo J, Bates M, Kapata N, Orba Y, Kajihara M, Takada A, Sawa H, Chilengi R, Simulundu E.
PMID: 34451471
Pathogens. 2021 Aug 10;10(8). doi: 10.3390/pathogens10081007.

Emerging and re-emerging mosquito-borne viral diseases are a threat to global health. This systematic review aimed to investigate the available evidence of mosquito-borne viral pathogens reported in Zambia. A search of literature was conducted in PubMed and Google Scholar...

Cite
Velu RM, Kwenda G, Libonda L, et al. Mosquito-Borne Viral Pathogens Detected in Zambia: A Systematic Review. Pathogens. 2021;10(8)doi: 10.3390/pathogens10081007.
Velu, R. M., Kwenda, G., Libonda, L., Chisenga, C. C., Flavien, B. N., Chilyabanyama, O. N., Simunyandi, M., Bosomprah, S., Sande, N. C., Changula, K., Muleya, W., Mburu, M. M., Mubemba, B., Chitanga, S., Tembo, J., Bates, M., Kapata, N., Orba, Y., Kajihara, M., Takada, A., Sawa, H., Chilengi, R., & Simulundu, E. (2021). Mosquito-Borne Viral Pathogens Detected in Zambia: A Systematic Review. Pathogens (Basel, Switzerland), 10(8), . https://doi.org/10.3390/pathogens10081007
Velu, Rachel Milomba, et al. "Mosquito-Borne Viral Pathogens Detected in Zambia: A Systematic Review." Pathogens (Basel, Switzerland) vol. 10,8 (2021). doi: https://doi.org/10.3390/pathogens10081007
Velu RM, Kwenda G, Libonda L, Chisenga CC, Flavien BN, Chilyabanyama ON, Simunyandi M, Bosomprah S, Sande NC, Changula K, Muleya W, Mburu MM, Mubemba B, Chitanga S, Tembo J, Bates M, Kapata N, Orba Y, Kajihara M, Takada A, Sawa H, Chilengi R, Simulundu E. Mosquito-Borne Viral Pathogens Detected in Zambia: A Systematic Review. Pathogens. 2021 Aug 10;10(8). doi: 10.3390/pathogens10081007. PMID: 34451471; PMCID: PMC8401848.
Copy Download .nbib Format: NLM
First report of Mycobacterium bovis in wild chacma baboons (Papio ursinus) at the human-wildlife interface area in Zambia.

Transboundary and emerging diseases

Squarre D, Chizimu J, Nakajima C, Muma JB, Hang'ombe BM, Simulundu E, Mwasinga W, Katampi J, Fandamu P, Mukonka V, Suzuki Y, Sawa H, Munang'andu HM, Shanungu G, Chambaro HM, Munyeme M.
PMID: 33900037
Transbound Emerg Dis. 2021 Apr 26; doi: 10.1111/tbed.14124. Epub 2021 Apr 26.

Mycobacterium bovis (M. bovis) causes tuberculosis in mammals and is a major public health threat worldwide. While M. bovis has been reported in humans, domestic and wild ruminants at the human-wildlife-livestock interface area in Zambia, there is paucity of...

Cite
Squarre D, Chizimu J, Nakajima C, et al. First report of Mycobacterium bovis in wild chacma baboons (Papio ursinus) at the human-wildlife interface area in Zambia. Transbound Emerg Dis. 2021;doi: 10.1111/tbed.14124.
Squarre, D., Chizimu, J., Nakajima, C., Muma, J. B., Hang'ombe, B. M., Simulundu, E., Mwasinga, W., Katampi, J., Fandamu, P., Mukonka, V., Suzuki, Y., Sawa, H., Munang'andu, H. M., Shanungu, G., Chambaro, H. M., & Munyeme, M. (2021). First report of Mycobacterium bovis in wild chacma baboons (Papio ursinus) at the human-wildlife interface area in Zambia. Transboundary and emerging diseases, . https://doi.org/10.1111/tbed.14124
Squarre, David, et al. "First report of Mycobacterium bovis in wild chacma baboons (Papio ursinus) at the human-wildlife interface area in Zambia." Transboundary and emerging diseases vol. (2021). doi: https://doi.org/10.1111/tbed.14124
Squarre D, Chizimu J, Nakajima C, Muma JB, Hang'ombe BM, Simulundu E, Mwasinga W, Katampi J, Fandamu P, Mukonka V, Suzuki Y, Sawa H, Munang'andu HM, Shanungu G, Chambaro HM, Munyeme M. First report of Mycobacterium bovis in wild chacma baboons (Papio ursinus) at the human-wildlife interface area in Zambia. Transbound Emerg Dis. 2021 Apr 26; doi: 10.1111/tbed.14124. Epub 2021 Apr 26. PMID: 33900037.
Copy Download .nbib Format: NLM
Living-donor lobar lung transplantation.

Journal of thoracic disease

Nakajima D, Date H.
PMID: 34992838
J Thorac Dis. 2021 Nov;13(11):6594-6601. doi: 10.21037/jtd-2021-07.

Living-donor lobar lung transplantation (LDLLT) has become an important life-saving option for patients with severe respiratory disorders, since it was developed by a group in the University of Southern California in 1993 and introduced in Japan in 1998 in...

Cite
Nakajima D, Date H. Living-donor lobar lung transplantation. J Thorac Dis. 2021;13(11):6594-6601doi: 10.21037/jtd-2021-07.
Nakajima, D., & Date, H. (2021). Living-donor lobar lung transplantation. Journal of thoracic disease, 13(11), 6594-6601. https://doi.org/10.21037/jtd-2021-07
Nakajima, Daisuke, and Date, Hiroshi. "Living-donor lobar lung transplantation." Journal of thoracic disease vol. 13,11 (2021): 6594-6601. doi: https://doi.org/10.21037/jtd-2021-07
Nakajima D, Date H. Living-donor lobar lung transplantation. J Thorac Dis. 2021 Nov;13(11):6594-6601. doi: 10.21037/jtd-2021-07. PMID: 34992838; PMCID: PMC8662478.
Copy Download .nbib Format: NLM
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression.

Cancer immunology research

Parajuli G, Tekguc M, Wing JB, Hashimoto A, Okuzaki D, Hirata T, Sasaki A, Itokazu T, Handa H, Sugino H, Nishikawa Y, Metwally H, Kodama Y, Tanaka S, Sabe H, Yamashita T, Sakaguchi S, Kishimoto T, Hashimoto S.
PMID: 34006522
Cancer Immunol Res. 2021 Aug;9(8):862-876. doi: 10.1158/2326-6066.CIR-21-0014. Epub 2021 May 18.

The acquisition of mesenchymal traits leads to immune evasion in various cancers, but the underlying molecular mechanisms remain unclear. In this study, we found that the expression levels of AT-rich interaction domain-containing protein 5a (Arid5a), an RNA-binding protein, were...

Cite
Parajuli G, Tekguc M, Wing JB, et al. Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer Immunol Res. 2021;9(8):862-876doi: 10.1158/2326-6066.CIR-21-0014.
Parajuli, G., Tekguc, M., Wing, J. B., Hashimoto, A., Okuzaki, D., Hirata, T., Sasaki, A., Itokazu, T., Handa, H., Sugino, H., Nishikawa, Y., Metwally, H., Kodama, Y., Tanaka, S., Sabe, H., Yamashita, T., Sakaguchi, S., Kishimoto, T., & Hashimoto, S. (2021). Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer immunology research, 9(8), 862-876. https://doi.org/10.1158/2326-6066.CIR-21-0014
Parajuli, Gyanu, et al. "Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression." Cancer immunology research vol. 9,8 (2021): 862-876. doi: https://doi.org/10.1158/2326-6066.CIR-21-0014
Parajuli G, Tekguc M, Wing JB, Hashimoto A, Okuzaki D, Hirata T, Sasaki A, Itokazu T, Handa H, Sugino H, Nishikawa Y, Metwally H, Kodama Y, Tanaka S, Sabe H, Yamashita T, Sakaguchi S, Kishimoto T, Hashimoto S. Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer Immunol Res. 2021 Aug;9(8):862-876. doi: 10.1158/2326-6066.CIR-21-0014. Epub 2021 May 18. PMID: 34006522.
Copy Download .nbib Format: NLM
Showing 625 to 630 of 630 entries